Spinal Cord Stimulation Shows 32% Arm Strength Gain in Stroke Pilot Trial

University of Pittsburgh查看公司主页 researchers have achieved a major milestone in stroke (搜索)搜索该疾病 rehabilitation, demonstrating that implanted spinal cord stimulation devices can significantly improve hand and arm mobility in chronic stroke survivors. In a four-week pilot clinical trial recently published in Nature Medicine, seven participants with profound motor deficits experienced an average 32% increase in arm strength, along with overall improvements in arm mobility and reductions in abnormal muscle stiffness from damaged nerve pathways.

All seven participants experienced a positive effect, regardless of initial mobility level, after less than nine hours of painless movement training.

"It is like a quantum change in the way that stroke (搜索)搜索该疾病 rehabilitation is being handled," said Dr. George Wittenberg, professor of neurology and physical medicine and rehabilitation at Pitt. "The nervous system is damaged in certain ways that no amount of practice will actually heal the nervous system and make you better able to use what you have. This adds to that in a huge way."

How the Technology Works

The approach uses cervical epidural spinal cord stimulation in the region controlling arm and hand movement through the implantation of thin electrodes along the neck. Electrical signals are sent to sensory nerve fibers in the spinal cord to enhance communication between the brain and weakened muscles, ultimately helping patients regain some level of control.

While spinal cord stimulation has been used for decades to treat chronic pain, this study marks its first application for restoring arm function following a stroke (搜索)搜索该疾病. The device is currently FDA-approved only for pain management.

"Normally the way we move is that our brain sends signals to some neurons in the spinal cord that then eventually control the muscles," explained Dr. Marco Capogrosso, director of the spinal cord stimulation laboratory at UPMC Rehabilitation Institute (搜索)搜索该词条 and associate professor of neurological surgery at Pitt. "After a stroke (搜索)搜索该疾病, those signals get substantially diminished. What our technology does … is amplify those signals. We're not substituting anything. We're just trying to facilitate whatever is left after stroke and help it as much as we can."

A Patient's Experience

Alex Signorini, a 66-year-old from Hempfield, suffered a hemorrhagic stroke (搜索)搜索该疾病 five years ago that robbed him of full mobility in his right arm, hand, and leg. After years of rehabilitation, he retained significant mobility deficits, including drop foot on his right side and an inability to fully open his hand.

When Signorini first had the device implanted in 2023, and during subsequent trials, he reported readily apparent instant improvement. "I could move my arm faster, quicker. I could move it higher," Signorini said. "The benefits you get from the stimulation, even when they did it and then they took it back out, some of the benefits were there till about January — so that was three months."

Signorini's personal goal was deeply meaningful: "My goal was in the beginning to be able to hug my girlfriend and daughter with both arms. I was able to do that."

Clinical Significance and Next Steps

Stroke (搜索)搜索该疾病 is the leading cause of adult paralysis in the United States, with approximately 400,000 people developing chronic arm and hand weakness each year, according to the American Heart Association. The effects of rehabilitation typically slow dramatically after six months, according to Johns Hopkins, making this new approach particularly significant for chronic stroke patients who have plateaued with conventional therapy.

The researchers note that lasting gains depend on continued use, as motor function declined after stimulation ceased in this initial safety and feasibility-focused study.

"We're seeing more acceptance of devices that are implanted surgically," Wittenberg said. "People already get pacemakers to keep their heart going, so why not have a spinal cord stimulator to keep their movement going?"

Capogrosso emphasized the human dimension of the work: "When you see that [progress] is happening, you quickly realize that you owe it to the patients to continue. It's not just that the patient participated in the trial and now you have a paper, and it's cool — it's not about you anymore. It becomes about them."

The team is currently recruiting for an extended clinical trial to examine the effects of longer-term stimulation both on its own and with the aid of physical therapy. Capogrosso believes that, absent any major hurdles, the technology could be approved for use in stroke (搜索)搜索该疾病 patients within three to five years.